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Abstract
Biogenic amines such as serotonin and dopamine are intercellular signaling molecules that function
widely as neurotransmitters and neuromodulators. We have identified in the nematode
Caenorhabditis elegans three ligand-gated chloride channels that are receptors for biogenic amines:
LGC-53 is a high-affinity dopamine receptor, LGC-55 is a high-affinity tyramine receptor, and
LGC-40 is a low-affinity serotonin receptor that is also gated by choline and acetylcholine. lgc-55
mutants are defective in a behavior that requires endogenous tyramine, indicating that this ionotropic
tyramine receptor functions in tyramine signaling in vivo. Our studies suggest that direct activation
of membrane chloride conductances is a general mechanism of action for biogenic amines in the
modulation of C. elegans behavior.
Biogenic amines function in diverse neuronal circuits as neurotransmitters and
neuromodulators. Therapeutics for many psychiatric disorders, including major depression,
schizophrenia and bipolar affective disorder, target signaling pathways of such biogenic amines
as serotonin, dopamine, and noradrenaline (1). Biogenic amine signaling pathways are also
targets of drugs of abuse (1). Almost all known biogenic amine receptors are G protein-coupled
receptors (GPCRs) that signal though the activation of heterotrimeric guanine nucleotide-
binding proteins (G proteins), which activate second-messenger signaling pathways. However,
there exists a second type of biogenic amine receptor: biogenic amine-gated ion channels. The
vertebrate 5-HT3 receptor is a serotonin-gated cation channel (2,3). Two arthropod histamine
receptors and the C. elegans MOD-1 serotonin receptor are biogenic amine-gated chloride
channels (4,5,6,7,8). These biogenic amine-gated channels from diverse phyla suggest a
mechanism of action for their cognate ligands: fast excitation or inhibition analogous to the
response to the activation of nicotinic acetylcholine receptors or to the activation of GABAA
receptors respectively. We report that such a mechanism of action for biogenic amines is more
general: a single species, C. elegans, expresses multiple ion channels gated by biogenic amines.
The known biogenic amine-gated ion channels are members of the Cys-loop family of ion
channels. Using database searches of proteins encoded by the C. elegans genome, we identified
26 presumptive Cys-loop family ion channels that are highly similar to the MOD-1 serotonin-
gated chloride channel (E values reported by the BLAST algorithm range from 10-35 to
10-94, Table S1); 23 have sequences in their pore-forming M2 transmembrane domains
predicted to confer chloride selectivity (9). We expressed these 26 receptors individually in
Xenopus laevis oocytes and tested them for receptor activity using a two-electrode voltage
clamp to monitor whole-cell currents evoked by application of a panel of agonists, including
the biogenic amines serotonin, dopamine, octopamine, tyramine and histamine (10). We
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identified three genes that encode ion channels activated by biogenic amines: lgc-40, lgc-53
and lgc-55. LGC-53 was activated with the highest efficacy by dopamine (Fig. 1A) with an
EC50 of 4.4 μM (Fig. 1B). LGC-55 was activated with the highest efficacy by tyramine with
an EC50 of 6.0 μM (Fig. 1C and D). LGC-40 was activated only by high concentrations of
serotonin (EC50 = 905 μM) (Fig. 1E and F). We tested whether other potential ligands could
be more effective and found that choline and acetylcholine gated LGC-40 at lower
concentrations (choline EC50 = 3.4 μM, acetylcholine EC50 = 87 μM) (Fig. 1F) (11).
Compounds that block ion channels endogenous to Xenopus oocytes failed to block agonist-
evoked whole-cell currents in oocytes expressing LGC-40, LGC-53 and LGC-55, indicating
that such endogenous channels did not mediate the agonist-evoked currents (Figure S1).
Ligand binding by Cys-loop family ion channels is mediated by the amino-terminal
extracellular domains of channel subunits (12). We aligned the extracellular domain sequences
of LGC-40, LGC-53 and LGC-55 with those of MOD-1 and 5-HT3 receptor subunits and of
other Cys-loop family receptors but did not identify any amino acids that were conserved
specifically among amine-gated channels (Figure S2).
All previously characterized dopamine receptors are GPCRs (1). We tested whether antagonists
of G protein-coupled dopamine receptors can inhibit the LGC-53 dopamine-gated ion channel.
Of seven antagonists tested (Fig. 2A), three acted with an IC50 of less than 100 μM: risperidone
(IC50 = 40 μM), haloperidol (IC50 = 32 μM) and spiperone (IC50 = 38 μM) (Fig. 2B-D)
(10). Risperidone, haloperidol and spiperone all are in clinical use as antipsychotics (1). Since
these drugs also block LGC-53, we suggest that some of their actions as therapeutics might be
through inhibition of a yet-to-be-identified human dopamine receptor that, like LGC-53, is
composed of Cys-loop family channel subunits.
We tested d-tubocurarine and atropine, antagonists of ionotropic and G protein-coupled
acetylcholine receptors, respectively (1), and hemicholinium-3, a blocker of the high-affinity
choline transporter (13), for effects on choline-evoked currents in oocytes expressing LGC-40
(Fig. 2F-G). LGC-40 currents were blocked by low concentrations of d-tubocurarine (IC50 =
8.3 μM) but were relatively insensitive to atropine (Fig. 2F). Hemicholinium-3 was the most
effective antagonist of the LGC-40 channel, with an IC50 of 2.0 μM (Fig. 2G). Thus, LGC-40
is sensitive both to a canonical antagonist of acetylcholine-gated ion channels as well as to an
inhibitor of the high-affinity choline transporter.
The presumptive M2 regions, which are predicted to determine the ion selectivity of Cys-loop
family ion channels, of LGC-40, LGC-53 and LGC-55 are more similar to the M2 regions of
known chloride channels than to those of known cation channels (Fig. 3A) (9,12). To test
whether these receptors are chloride channels, we measured the reversal potentials of agonist-
evoked currents in Xenopus oocytes expressing LGC-40, LGC-53 and LGC-55 (Fig. 3B
through D). In solutions containing 96 mM Na+ and 104 mM Cl-, ligand-evoked currents
reversed at -23 to -26 mV, close to the reversal potential for chloride in Xenopus oocytes
(14). Replacement of sodium ions with N-methyl D-gluconate (NMDG) or choline did not alter
the reversal potentials of the evoked currents. Replacement of chloride ions with gluconate
shifted the reversal potentials positively by 17 to 31 mV (Fig. 3B through D) (15). These data
indicate that LGC-40, LGC-53 and LGC-55 are chloride channels. The observed shift in
reversal potential was less than predicted for channels that are perfectly selective for chloride
over other anions (our unpublished observations); perhaps these channels might also pass the
anions we used to replace chloride.
To identify biological functions of these amine-gated chloride channels, we isolated lgc-40,
lgc-53 and lgc-55 deletion mutants (Figure S3). lgc-55 mutants, which lack the tyramine-gated
chloride channel, had a behavioral defect that indicated an in vivo function for this receptor in
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tyraminergic signaling. Tyramine from the RIM motor neurons suppresses small rapid head
movements during touch-evoked locomotory reversals (16). Animals lacking endogenous
tyramine fail to suppress these head oscillations and exhibit the Sho phenotype (Suppression
of head oscillations-defective), as do animals lacking the tyraminergic RIM motor neurons
(16) (Figure 4A). Similarly, lgc-55 mutants continued to execute head movements during
touch-evoked reversals (Fig. 4A). The Sho phenotype of lgc-55 mutants was rescued by
transgenes containing the lgc-55 cDNA fused to lgc-55 promoter sequences and by transgenes
containing the lgc-55 cDNA fused to the unc-119 promoter, which drives expression broadly
in the nervous system (17). To identify cells that express LGC-55, we created transgenic
animals expressing GFP under the control of the lgc-55 promoter (17). We observed expression
of this reporter transgene in head muscles and in the glia-like GLR cells, which are connected
to the head muscles by gap junctions (18), and weaker expression in many unidentified head
neurons (Figure 4B). We also observed strong expression in the ALM and AVM
mechanosensory neurons (data not shown). Expression of lgc-55 in muscles, including in head
muscles, did not rescue the Sho phenotype of lgc-55 mutants (Fig. 4a). Our findings suggest
that LGC-55 can act in the GLR cells or neurons to control head movements and establish that
the LGC-55 tyramine receptor functions in vivo in the tyraminergic control of head movements.
No behavioral abnormalities were detected in mutants that carry deletions in lgc-40 and
lgc-53 (19).
We conclude that including MOD-1 there exist in C. elegans at least four ligand-gated chloride
channels that can be activated by biogenic amines. Our results indicate that ligand-gated
chloride channels constitute a class of receptor for biogenic amines and that direct activation
of membrane chloride conductances is a general mechanism of biogenic amine action in C.
elegans. Biogenic amine-gated chloride channels might exist in the nervous systems of animals
other than C. elegans and arthropods. In molluscs, synaptic dopamine rapidly activates a
chloride conductance that is blocked by picrotoxin, an antagonist of ligand-gated chloride
channels (20,21,22). In the mammalian brain, histaminergic neurons project to the
hypothalamus and use rapid inhibitory synaptic signals that are (i) not mediated by G protein
signaling, (ii) are picrotoxin-sensitive and (iii) are mediated by chloride conductances (23).
The molecular identity of the histamine receptor in this synapse is not known, but the recent
demonstration that GABAA receptor subunits can form histamine-gated chloride channels in
vitro suggests that an ionotropic histamine receptor might contain known ligand-gated chloride
channel subunits (24). If direct activation of ligand-gated chloride channels is a mechanism of
biogenic amine action in the mammalian brain, such receptors might be therapeutic targets,
given the many links between aminergic signaling and psychiatric disorders (1,25).
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Figure 1. Biogenic amines evoke currents in Xenopus oocytes expressing LGC-53, LGC-55 or
LGC-40
A, C, E. Whole-cell currents recorded from Xenopus oocytes expressing LGC-53, LGC-55 or
LGC-40 during application of serotonin (5-HT), dopamine (DA), octopamine (OA), tyramine
(TA) and histamine (HA). The concentrations of applied neurotransmitters were 10 μM in
panels (A) and (B) and 100 μM in (C).
B, D. Dose-response curves for dopamine and tyramine-evoked currents in Xenopus oocytes
expressing LGC-53 and LGC-55, respectively. Each point (± s.e.m.) represents the average of
three to five recordings. Dose-response data were fitted to the Hill equation and normalized to
Imax. The half-effector concentration (EC50) of dopamine for LGC-53 was 4.4 μM, and the
estimated Hill coefficient was 1.9. The half-effector concentration of tyramine for LGC-55
was 6.0 μM, and the estimated Hill coefficient was 1.8.
F. Dose-response curves for serotonin, acetylcholine and choline-evoked currents in
Xenopus oocytes expressing LGC-40. Dose-response data were fitted to the Hill equation and
normalized to Imax. n ≥ 5. The half-effector concentration of serotonin for LGC-40 was 905
μM, and the estimated Hill coefficient was 2.7. The half-effector concentrations of
acetylcholine and choline for LGC-40 were 87 μM and 3.4 μM, respectively, and the estimated
Hill coefficients were 1.5 and 1.9, respectively.
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Figure 2. Pharmacological characterizations of the ionotropic dopamine receptor LGC-53 and the
ionotropic choline receptor LGC-40
A. Inhibition of LGC-53 currents by dopamine-receptor antagonists. The mean ratios (± s.e.m.)
of the peak currents evoked in the presence and absence of the indicated dopamine receptor
antagonist are shown. n ≥ 5. Drugs were tested at a concentration of 100 μM, and 5 μM
dopamine was used to evoke LGC-53 currents.
B-D. Dose-response curves for the inhibiton by haloperidol, risperidone, and spiperone of
LGC-53 currents. 5 μM dopamine was used to evoke currents in oocytes expressing LGC-53
in the presence of different concentrations of dopamine receptor antagonists. Currents were
normalized to the current evoked by 5 μM dopamine in the absence of receptor antagonists.
n ≥ 5.
E-F. Dose-response curves for the inhibition by atropine, d-tubocurarine, and hemicholinium-3
of LGC-40 currents. Currents were evoked by 2 μM choline in oocytes expressing LGC-40 in
the presence of different concentrations of compounds. Currents were normalized the current
evoked by 2 μM choline in the absence of any compounds. n ≥ 5.
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Figure 3. LGC-40, LGC-53 and LGC-55 are chloride channels
A. Alignment of sequences from the presumptive M2 region of amine-gated ion channels,
which determines ion selectivity of Cys-loop family ion channels (9,12). Cation-selective 5-
HT3 receptor subunits are labeled in green, and anion-selective MOD-1, HCLA, and HCLB
subunits are labeled in red.
B-D. I-V curves of LGC-40, LGC-53 and LGC-55 in ND96 medium (which contains 96 mM
sodium and 104 mM chloride), sodium-free medium (0 mM sodium and 104 mM chloride) or
low-chloride medium (96 mM sodium and 8 mM chloride). The mean reversal potential ±
s.e.m. from four to five experiments under each condition is shown.
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Figure 4. LGC-55 is required for the tyraminergic modulation of head movements by C. elegans
and is expressed in the GLR glia-like cells and head muscles
A. The fractions of animals that are suppression of head oscillations-defective (Sho) are plotted
for the wild type, tdc-1, and lgc-55 mutants and lgc-55 mutants carrying rescuing transgenes
that express the lgc-55 cDNA using its own promoter, the pan-neuronal unc-119 promoter, or
the pan-muscle myo-3 promoter. In each experiment we tested 20 individuals of each genotype
for the Sho phenotype. The mean fraction of animals with the Sho phenotype ± s.e.m. is plotted,
n ≥ 3. Three independent lines (labeled #1-3) carrying each transgene were assayed.
B. Expression of lgc-55. An lgc-55∷gfp reporter transgene is expressed in the GLR glia-like
cells and head muscles (16). Arrowheads indicate some of the unidentified head neurons that
express the reporter transgene. The tyraminergic RIM neurons, which provide the tyramine
that inhibits head movements during reversals, are labeled with a tdc-1∷dsRed reporter
transgene.
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